Euromedicare International Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.00 M
- Company Age 9 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.56 M
- Revenue Growth 1.58%
- Profit Growth 113.93%
- Ebitda 11.13%
- Net Worth 44.10%
- Total Assets 27.02%
About Euromedicare International
Euromedicare International Private Limited (EIPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 January 2016 (Nine years 24 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹0.56 M.
Rajamouli Janagam, Shobha Jangam, and Janagam Itihas serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100TG2016PTC102631
- Company No.
102631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Euromedicare International?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janagam Itihas  | Director | 17-Dec-2019 | Current |
| Rajamouli Janagam | Director | 07-Jan-2016 | Current |
| Shobha Jangam | Director | 07-Jan-2016 | Current |
Financial Performance of Euromedicare International.
Euromedicare International Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.58% increase. The company also saw a substantial improvement in profitability, with a 113.93% increase in profit. The company's net worth Soared by an impressive increase of 44.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Euromedicare International?
Unlock access to Euromedicare International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tabeazy Private LimitedJanagam Itihas is a mutual person
Sri Pharma India Private LimitedRajamouli Janagam and Shobha Jangam are mutual person
- Arranoa Infra Developers Private Limited
Janagam Itihas is a mutual person
Charges (Loans)
₹0.06 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jan 2020 | Indian Overseas Bank | ₹0.56 M | Open |
How Many Employees Work at Euromedicare International?
Unlock and access historical data on people associated with Euromedicare International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euromedicare International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euromedicare International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.